NCT05672914

Brief Summary

Cigarette smoking is the leading cause of death and disability in the United States. People with psychiatric disorders consume almost half (44.3%) of all cigarettes smoked in the U.S. and have life spans more than 20 years shorter than the general population. Effective quit smoking treatments for people with psychiatric disorders are sorely needed. When patients are hospitalized for a psychiatric disorder, they are not allowed to smoke. This enforced period of no smoking creates what professionals call "a teachable moment". It provides an excellent opportunity to discuss the prospect of staying quit once the individual leaves the hospital. In ongoing research, the investigators have developed and tested a Sustained Care quit smoking intervention for smokers engaged in a psychiatric hospitalization. The intervention includes: 1) a professionally-led, motivational counseling session to encourage quitting smoking and increase awareness about available quit smoking resources, 2) a referral to the Texas Tobacco Quitline for phone-based, quit smoking counseling, and 3) an offer of 8 weeks of nicotine patches after leaving the hospital. Findings from a recently completed clinical trial provide strong support for this Sustained Care intervention. Aims in the current project are to develop and test a tablet computer-based, motivational counseling intervention that does not require a trained professional counselor. The goal is to conduct a clinical trial to demonstrate the effectiveness of this tablet-based, Sustained Care intervention for smokers engaged in psychiatric hospitalization. As before, the same quit smoking resources (Quitline and nicotine patches) will be provided upon hospital discharge. If successful, next steps will involve plans to implement this quit smoking intervention in psychiatric hospitals throughout Texas, in order to reduce the burden caused by tobacco-related cancers among the citizens of Texas.

Trial Health

77
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
250

participants targeted

Target at P75+ for not_applicable

Timeline
1mo left

Started Aug 2023

Typical duration for not_applicable

Geographic Reach
1 country

1 active site

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress96%
Aug 2023Aug 2026

First Submitted

Initial submission to the registry

December 21, 2022

Completed
15 days until next milestone

First Posted

Study publicly available on registry

January 5, 2023

Completed
7 months until next milestone

Study Start

First participant enrolled

August 10, 2023

Completed
2.7 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

May 1, 2026

Completed
3 months until next milestone

Study Completion

Last participant's last visit for all outcomes

August 1, 2026

Expected
Last Updated

May 8, 2024

Status Verified

May 1, 2024

Enrollment Period

2.7 years

First QC Date

December 21, 2022

Last Update Submit

May 6, 2024

Conditions

Outcome Measures

Primary Outcomes (1)

  • Smoking cessation

    Binomial outcome of continued smoking abstinence vs. relapse modeled over time and controlling for gender and magnitude of initial nicotine dependence

    1, 3, and 6 months after hospital discharge

Secondary Outcomes (1)

  • Number of quit attempts

    First month following hospital discharge

Study Arms (2)

Tablet-based Sustained Care

EXPERIMENTAL

Intervention to support sustained smoking cessation.

Behavioral: Tablet-based sustained care

Usual Care

NO INTERVENTION

Standard hospital care: : A brief (5-10 min.) tobacco education session from a hospital nurse, along with educational materials about quitting and a quitline brochure.

Interventions

A tablet-based motivational-interviewing intervention, tailored specifically to smokers with psychiatric disorders, to motivate the use of evidence-based tobacco treatment and cessation in cigarette smokers upon discharge from an inpatient psychiatric hospitalization. In addition, participants will receive standard hospital tobacco care (see Usual Care Arm).

Tablet-based Sustained Care

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Male or female patients above the age of 18 capable of providing informed consent
  • Current smoker (at least 5 cigarettes/day when not hospitalized)
  • Willing and able to provide informed consent, attend all study visits, and comply with the protocol

You may not qualify if:

  • Mini-Mental State Examination (MMSE) score \< 24
  • Current diagnosis of dementia or other cognitive impairment that would limit study participation
  • Inability to provide consent for study participation due to his/her inability to demonstrate an understanding of study procedures
  • Current diagnosis of a (non-nicotine) substance use disorder requiring detoxification
  • No access to or inability to communicate by phone, or no stable mailing address
  • Planned discharge to institutional care (e.g., nursing home, long-term rehabilitation, jail, etc.)
  • Medical contraindication to nicotine patch use
  • Currently pregnant or breastfeeding

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Ascension Shoal Creek

Austin, Texas, 78731, United States

RECRUITING

MeSH Terms

Conditions

Smoking Cessation

Condition Hierarchy (Ancestors)

Health BehaviorBehavior

Study Officials

  • Richard Brown, Ph.D.

    The University of Texas at Austin

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Richard Brown, Ph.D.

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Research Professor

Study Record Dates

First Submitted

December 21, 2022

First Posted

January 5, 2023

Study Start

August 10, 2023

Primary Completion

May 1, 2026

Study Completion (Estimated)

August 1, 2026

Last Updated

May 8, 2024

Record last verified: 2024-05

Data Sharing

IPD Sharing
Will not share

Locations